$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

$jazz Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000123252422000035 Filed on August 03, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$940.7M	$932.9M	$813.7M
YoY Change	12.23%	24.08%	33.93%
Cost Of Revenue	$133.7M	$124.2M	$115.3M
YoY Change	-7.96%	4.21%	186.78%
Gross Profit	$807.0M	$808.7M	$698.4M
YoY Change	16.47%	27.83%	23.09%
Gross Profit Margin	85.79%	86.69%	85.83%
Selling, General & Admin	$358.5M	$366.5M	$308.8M
YoY Change	-1.43%	-14.58%	18.54%
% of Gross Profit	44.42%	45.32%	44.21%
Research & Development	$148.9M	$139.0M	$130.0M
YoY Change	5.55%	4.79%	69.75%
% of Gross Profit	18.45%	17.19%	18.61%
Depreciation & Amortization	$148.8M	$156.2M	$7.617M
YoY Change	-11.19%	6.05%	59.38%
% of Gross Profit	18.44%	19.32%	1.09%
Operating Expenses	$507.3M	$505.5M	$438.8M
YoY Change	0.52%	-10.01%	30.17%
Operating Profit	$24.76M	$85.55M	$87.55M
YoY Change	-12.71%	-222.93%	-46.0%
Interest Expense	-$80.24M	-$63.19M	-$70.68M
YoY Change	-14.06%	-8.98%	158.2%
% of Operating Profit	-324.05%	-73.87%	-80.74%
Other Income/Expense, Net
YoY Change
Pretax Income	-$60.13M	$21.01M	$6.325M
YoY Change	-11.1%	-115.44%	-95.34%
Income Tax	-$43.00M	-$16.10M	$500.0K
% Of Pretax Income		-76.62%	7.91%
Net Earnings	-$19.65M	$34.67M	$1.647M
YoY Change	-62.81%	-109.54%	-98.65%
Net Earnings / Revenue	-2.09%	3.72%	0.2%
Basic Earnings Per Share	-$0.31	$0.56	$0.03
Diluted Earnings Per Share	-$0.31	$0.55	$0.03
COMMON SHARES
Basic Shares Outstanding	62.68M shares	62.44M shares	61.87M shares
Diluted Shares Outstanding	62.79M shares	63.43M shares	62.91M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$899.4M	$771.3M	$490.8M
YoY Change	33.88%	-13.48%	-79.82%
Cash & Equivalents	$839.4M	$711.3M	$490.8M
Short-Term Investments	$120.0M	$100.0M	$80.71M
Other Short-Term Assets	$250.0M	$255.5M	$243.9M
YoY Change	11.07%	27.64%	65.09%
Inventory	$728.1M	$861.7M	$985.5M
Prepaid Expenses	$92.88M	$108.3M	$117.4M
Receivables	$601.2M	$594.0M	$572.4M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.572B	$2.591B	$2.501B
YoY Change	-2.16%	-12.29%	-21.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$290.1M	$317.9M	$341.0M
YoY Change	-15.83%	-25.43%	175.34%
Goodwill	$1.593B	$1.688B	$1.782B
YoY Change	-13.89%	-10.6%	89.95%
Intangibles	$5.570B	$6.238B	$6.783B
YoY Change	-23.51%	-17.79%	221.77%
Long-Term Investments
YoY Change
Other Assets	$35.15M	$34.61M	$35.51M
YoY Change	-23.21%	-26.49%	16.99%
Total Long-Term Assets	$7.813B	$8.609B	$9.268B
YoY Change	-20.68%	-16.08%	158.19%
TOTAL ASSETS
Total Short-Term Assets	$2.572B	$2.591B	$2.501B
Total Long-Term Assets	$7.813B	$8.609B	$9.268B
Total Assets	$10.38B	$11.20B	$11.77B
YoY Change	-16.78%	-15.23%	74.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$102.2M	$74.16M	$73.34M
YoY Change	60.23%	14.4%	-5.66%
Accrued Expenses	$668.4M	$593.2M	$604.7M
YoY Change	10.71%	5.72%	61.67%
Deferred Revenue	$871.0K	$1.278M	$1.686M
YoY Change	-61.58%	-47.64%	-28.95%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$31.00M	$31.00M	$31.00M
YoY Change	0.0%	-87.53%	-87.53%
Total Short-Term Liabilities	$813.0M	$705.4M	$737.4M
YoY Change	10.6%	-19.89%	-1.95%
LONG-TERM LIABILITIES
Long-Term Debt	$5.696B	$5.990B	$5.993B
YoY Change	-8.83%	-7.69%	223.41%
Other Long-Term Liabilities	$123.9M	$129.4M	$124.6M
YoY Change	-10.07%	-2.33%	17.74%
Total Long-Term Liabilities	$5.820B	$6.119B	$6.118B
YoY Change	-8.85%	-7.59%	212.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$813.0M	$705.4M	$737.4M
Total Long-Term Liabilities	$5.820B	$6.119B	$6.118B
Total Liabilities	$6.633B	$6.825B	$6.855B
YoY Change	-6.85%	-9.03%	152.86%
SHAREHOLDERS EQUITY
Retained Earnings	$974.3M	$994.0M	$959.3M
YoY Change	12.56%	8.23%	-25.15%
Common Stock	$3.388B	$3.312B	$3.239B
YoY Change	-2.36%	-2.68%	20.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.745B	$3.201B	$3.608B
YoY Change
Total Liabilities & Shareholders Equity	$10.38B	$11.20B	$11.77B
YoY Change	-16.78%	-15.23%	74.19%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$19.65M	$34.67M	$1.647M
YoY Change	-62.81%	-109.54%	-98.65%
Depreciation, Depletion And Amortization	$148.8M	$156.2M	$7.617M
YoY Change	-11.19%	6.05%	59.38%
Cash From Operating Activities	$418.0M	$303.0M	$209.0M
YoY Change	52.52%	626.84%	-26.67%
INVESTING ACTIVITIES
Capital Expenditures	$4.902M	-$81.43M	$12.29M
YoY Change	-118.7%	1039.46%	466.97%
Acquisitions
YoY Change
Other Investing Activities	-$300.0K	-$7.736M	$0.00
YoY Change	-49.49%	-99.87%	-100.0%
Cash From Investing Activities	$4.602M	-$89.16M	-$37.29M
YoY Change	-117.16%	-98.49%	-105.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-289.1M	10.78M	-$270.8M
YoY Change	-37.86%	-99.77%	-1581.78%
NET CHANGE
Cash From Operating Activities	418.0M	303.0M	$209.0M
Cash From Investing Activities	4.602M	-89.16M	-$37.29M
Cash From Financing Activities	-289.1M	10.78M	-$270.8M
Net Change In Cash	133.5M	224.7M	-$100.6M
YoY Change	-161.28%	-118.62%	-109.68%
FREE CASH FLOW
Cash From Operating Activities	$418.0M	$303.0M	$209.0M
Capital Expenditures	$4.902M	-$81.43M	$12.29M
Free Cash Flow	$413.1M	$384.5M	$196.7M
YoY Change	37.57%	687.22%	-30.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001232524
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Registrant Name EntityRegistrantName	Jazz Pharmaceuticals plc
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33500
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L2
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1032470
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Fifth Floor, Waterloo Exchange,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Waterloo Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin 4
	dei	Entity Address Country EntityAddressCountry	IE
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	D04 E5W7
	dei	Country Region CountryRegion	353
	dei	City Area Code CityAreaCode	1
	dei	Local Phone Number LocalPhoneNumber	634-7800
	dei	Security12b Title Security12bTitle	Ordinary shares, nominal value $0.0001 per share
	dei	Trading Symbol TradingSymbol	JAZZ
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62680737	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	711265000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	591448000	usd
CY2022Q2	us-gaap	Investments Investments	60000000	usd
CY2021Q4	us-gaap	Investments Investments	0	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	594034000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	563360000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	861705000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1072721000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	108304000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	131413000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	255525000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	252392000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	2590833000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	2611334000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	239523000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	256837000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	78365000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86586000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6237959000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7152328000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1687648000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1827609000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	320550000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	311103000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	10643000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	12029000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34612000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	40813000	usd
CY2022Q2	us-gaap	Assets Assets	11200133000	usd
CY2021Q4	us-gaap	Assets Assets	12298639000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	74161000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	100298000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	593207000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	666304000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	31000000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	31000000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	5796000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	9608000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1278000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2093000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	705442000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	809303000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	231000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	463000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5989998000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6018943000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	77845000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87200000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1096416000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1300541000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	129420000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	116998000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2022Q2	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	usd
CY2021Q4	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	usd
CY2022Q2	jazz	Capital Redemption Reserve CapitalRedemptionReserve	472000	usd
CY2021Q4	jazz	Capital Redemption Reserve CapitalRedemptionReserve	472000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3312319000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3534792000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1106029000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-400360000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	993958000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	830226000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3200781000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3965191000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11200133000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12298639000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	932878000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	751811000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1746599000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1359392000	usd
CY2022Q2	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	124208000	usd
CY2021Q2	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	119194000	usd
	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	239492000	usd
	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	159383000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	366473000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	429031000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	675286000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	689539000	usd
CY2022Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	139047000	usd
CY2021Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	132696000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	269028000	usd
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	209269000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	148456000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	140480000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	320550000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	208672000	usd
CY2022Q2	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	69148000	usd
CY2021Q2	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	usd
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	69148000	usd
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	847332000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	821401000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1573504000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1266863000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	85546000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-69590000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	173095000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	92529000	usd
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-63189000	usd
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-69420000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-133873000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-96796000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1343000	usd
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2950000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11883000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3893000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	21014000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-136060000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27339000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-374000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16112000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	228621000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15576000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	246640000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2461000	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1365000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6603000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5530000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	34665000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-363316000	usd
	us-gaap	Net Income Loss NetIncomeLoss	36312000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-241484000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.17
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.17
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62436000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59448000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62152000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57966000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63431000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59448000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63171000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57966000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	34665000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-363316000	usd
	us-gaap	Net Income Loss NetIncomeLoss	36312000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-241484000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-515309000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-12303000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-705797000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-58523000	usd
CY2022Q2	jazz	Other Comprehensive Income Loss Fair Value Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationTax	0	usd
CY2021Q2	jazz	Other Comprehensive Income Loss Fair Value Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationTax	0	usd
	jazz	Other Comprehensive Income Loss Fair Value Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationTax	-43000	usd
	jazz	Other Comprehensive Income Loss Fair Value Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationTax	0	usd
CY2022Q2	jazz	Other Comprehensive Income Loss Fair Value Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax	0	usd
CY2021Q2	jazz	Other Comprehensive Income Loss Fair Value Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax	0	usd
	jazz	Other Comprehensive Income Loss Fair Value Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax	128000	usd
	jazz	Other Comprehensive Income Loss Fair Value Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	-167000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	0	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	-333000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-1169000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	0	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-2329000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	1000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	0	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-2000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	2000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	0	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-14000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax	-125000	usd
	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax	0	usd
	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Reclassification Adjustment Tax OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax	-125000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	375000	usd
	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	0	usd
	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax	375000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-515309000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11507000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-705669000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-56583000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-480644000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-374823000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-669357000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-298067000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3965191000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	21729000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	33776000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50106000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-190360000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1647000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3608487000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16640000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	8234000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	6289000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54407000	usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	54000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-515309000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	34665000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3200781000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3659745000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50407000	usd
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	23784000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34565000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-45076000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	121832000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	3797689000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	608456000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	43600000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	8282000	usd
CY2021Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3388000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48119000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11507000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-363316000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	4131490000	usd
	us-gaap	Net Income Loss NetIncomeLoss	36312000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-241484000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	320550000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	208672000	usd
	jazz	Inventory Step Up Value Adjustment InventoryStepUpValueAdjustment	132225000	usd
	jazz	Inventory Step Up Value Adjustment InventoryStepUpValueAdjustment	65991000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	103757000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	82648000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-82315000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	171587000	usd
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	69148000	usd
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-40814000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
	jazz	Noncash Interest Expense NoncashInterestExpense	17740000	usd
	jazz	Noncash Interest Expense NoncashInterestExpense	38010000	usd
	us-gaap	Depreciation Depreciation	15364000	usd
	us-gaap	Depreciation Depreciation	11614000	usd
	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	6150000	usd
	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	8742000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	29095000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2983000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34231000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34838000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	41929000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29402000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22654000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	21351000	usd
	jazz	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	-6939000	usd
	jazz	Increase Decrease In Operating Lease Assets IncreaseDecreaseInOperatingLeaseAssets	-7893000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	329000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	173000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-24771000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	19309000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-44430000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	56688000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-4468000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-21839000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1047000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-911000	usd
	jazz	Increase Decrease In Operating Lease Liabilities Noncurrent IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent	-8085000	usd
	jazz	Increase Decrease In Operating Lease Liabilities Noncurrent IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent	-8790000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	11062000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	11343000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	512015000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	326692000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	53000000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24570000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9346000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	26100000	usd
	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	69148000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25000000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	60736000	usd
	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	0	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1095000000	usd
	jazz	Payment To Acquire Assets Net Of Cash Acquired PaymentToAcquireAssetsNetOfCashAcquired	0	usd
	jazz	Payment To Acquire Assets Net Of Cash Acquired PaymentToAcquireAssetsNetOfCashAcquired	6234792000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-126454000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5175238000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	46603000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	102289000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	54000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	40065000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	27172000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	266518000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	584268000	usd
	jazz	Proceeds From Issuance Of Term Loan ProceedsFromIssuanceOfTermLoan	0	usd
	jazz	Proceeds From Issuance Of Term Loan ProceedsFromIssuanceOfTermLoan	3719930000	usd
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	usd
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	1471533000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-260034000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4682312000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5710000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-135000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	119817000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-166369000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	591448000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1057769000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	711265000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	891400000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:14pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	311103000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6018943000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	830226000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3534792000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:14pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents, investments and derivative contracts. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and investments to the extent recorded on the balance sheet.</span></div>We manage our foreign currency transaction risk and interest rate risk within specified guidelines through the use of derivatives. All of our derivative instruments are utilized for risk management purposes, and we do not use derivatives for speculative trading purposes.The counterparties to these contracts are large multinational commercial banks, and we believe the risk of nonperformance is not significant.We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the U.S., and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding.We depend on single source suppliers for most of our products, product candidates and their active pharmaceutical ingredients, or APIs. With respect to our oxybate products, the API is manufactured for us by a single source supplier and the finished products are manufactured both by us in our facility in Athlone, Ireland and by our U.S.-based supplier.
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	771265000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	771265000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	711265000	usd
CY2022Q2	us-gaap	Investments Investments	60000000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	591448000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	591448000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	591448000	usd
CY2021Q4	us-gaap	Investments Investments	0	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	700000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	900000	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	400000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1500000	usd
CY2022Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5500000	usd
CY2022Q2	us-gaap	Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement	24033000	usd
CY2021Q4	us-gaap	Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement	18419000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	26802000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21550000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	646647000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	886849000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	188256000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	164322000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	861705000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1072721000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1827609000	usd
	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	12927000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-127034000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1687648000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7520488000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1421696000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6098792000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8210692000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1213350000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6997342000	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	7659655000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1421696000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6237959000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8365678000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1213350000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7152328000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	285275000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	570550000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	570550000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	570550000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	570550000	usd
CY2022Q2	jazz	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	3531317000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6098792000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	336205000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	342208000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	96682000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	85371000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	239523000	usd
CY2022Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	13121000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	256837000	usd
CY2022Q2	jazz	Deferred Tax Intercompany Profit Current DeferredTaxIntercompanyProfitCurrent	204949000	usd
CY2021Q4	jazz	Deferred Tax Intercompany Profit Current DeferredTaxIntercompanyProfitCurrent	203480000	usd
CY2022Q2	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	50576000	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	48912000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	255525000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	252392000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	22507000	usd
CY2022Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	19295000	usd
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	20345000	usd
CY2022Q2	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	261199000	usd
CY2021Q4	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	215397000	usd
CY2022Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	94646000	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	158870000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	34992000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	48640000	usd
CY2022Q2	jazz	Accrued Clinical Trial Liability AccruedClinicalTrialLiability	25380000	usd
CY2021Q4	jazz	Accrued Clinical Trial Liability AccruedClinicalTrialLiability	25612000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	24033000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	18419000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	19784000	usd
CY2022Q2	jazz	Sales Return Reserve SalesReturnReserve	18708000	usd
CY2021Q4	jazz	Sales Return Reserve SalesReturnReserve	15814000	usd
CY2022Q2	jazz	Lease Liability Current LeaseLiabilityCurrent	15499000	usd
CY2021Q4	jazz	Lease Liability Current LeaseLiabilityCurrent	15763000	usd
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	21566000	usd
CY2022Q2	jazz	Accrued Inventory Related Liabilities AccruedInventoryRelatedLiabilities	7542000	usd
CY2021Q4	jazz	Accrued Inventory Related Liabilities AccruedInventoryRelatedLiabilities	16166000	usd
CY2022Q2	jazz	Accrued Milestones AccruedMilestones	5000000	usd
CY2021Q4	jazz	Accrued Milestones AccruedMilestones	25000000	usd
CY2022Q2	jazz	Accrued Construction In Progress AccruedConstructionInProgress	4361000	usd
CY2021Q4	jazz	Accrued Construction In Progress AccruedConstructionInProgress	2894000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	49647000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	59311000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	593207000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	666304000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	6020998000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	6049943000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	31000000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	31000000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5989998000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6018943000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	15500000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	31000000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	606000000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	31000000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1031000000	usd
CY2022Q2	jazz	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	4429500000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6144000000	usd
CY2022Q2	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	59100000	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-705797000	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-128000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-705669000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	34665000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-363316000	usd
	us-gaap	Net Income Loss NetIncomeLoss	36312000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-241484000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62436000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59448000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62152000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57966000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	995000	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1019000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63431000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59448000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63171000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57966000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.17
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	751811000	usd
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.17
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	932878000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	751811000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1746599000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1359392000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	932878000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1746599000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1359392000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2556000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1047000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1509000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	53687000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	48163000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	103757000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	82648000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	11140000	usd
CY2021Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8178000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	19963000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	14931000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	42547000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	39985000	usd
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	83794000	usd
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	67717000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16100000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15600000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	228600000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	246600000	usd

Files In Submission

Name	View Source	Status
0001232524-22-000035-index-headers.html	Edgar Link	pending
0001232524-22-000035-index.html	Edgar Link	pending
0001232524-22-000035.txt	Edgar Link	pending
0001232524-22-000035-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
jazz-20220630.htm	Edgar Link	pending
jazz-20220630.xsd	Edgar Link	pending
jazz-20220630_cal.xml	Edgar Link	unprocessable
jazz-20220630_def.xml	Edgar Link	unprocessable
jazz-20220630_htm.xml	Edgar Link	completed
jazz-20220630_lab.xml	Edgar Link	unprocessable
jazz-20220630_pre.xml	Edgar Link	unprocessable
jazzq22022ex101.htm	Edgar Link	pending
jazzq22022ex102.htm	Edgar Link	pending
jazzq22022ex311.htm	Edgar Link	pending
jazzq22022ex312.htm	Edgar Link	pending
jazzq22022ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

2022 Q3 Form 10-Q Financial Statement

#000123252422000035 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ Jazz Pharmaceuticals PLC Stock $jazz

2022 Q3 Form 10-Q Financial Statement

#000123252422000035 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz